Peptide–Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells-Reference-Cited by-同舟云学术

Peptide–Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells

Published:2023-02-21 Issue:5 Volume:66 Page:3348-3355
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Linares Jenniffer¹^ORCID,Varese Monica²,Sallent-Aragay Anna¹,Méndez Ana³,Palomo-Ponce Sergio⁴⁵^ORCID,Iglesias Mar¹⁴⁶,Batlle Eduard⁴⁵⁷,Pisonero Jorge⁸^ORCID,Montagut Clara¹⁴⁹¹⁰,Giralt Ernest²¹¹^ORCID,Lo Re Daniele²^ORCID,Calon Alexandre¹^ORCID

Affiliation:

1. Cancer Program, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain

2. Department of Chemistry, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain

3. Scientific and Technological Resources (SCTs), University of Oviedo, 33600 Mieres, Spain

4. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain

5. Department of Cancer, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain

6. Pathology Department, Hospital del Mar, 08003 Barcelona, Spain

7. Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain

8. Department of Physics, Faculty of Science, University of Oviedo, 33005 Oviedo, Spain

9. Medical Oncology Department, Hospital del Mar, 08003 Barcelona, Spain

10. Universitat Pompeu Fabra, 08002 Barcelona, Spain

11. Department of Inorganic and Organic Chemistry, University of Barcelona, 08028 Barcelona, Spain

Funder

European Commission

Ministerio de Econom?a y Competitividad

Fundaci?n Cient?fica Asociaci?n Espa?ola Contra el C?ncer

Instituto de Salud Carlos III

Ag?ncia de Gesti? d'Ajuts Universitaris i de Recerca